MedPath

Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil

Not Applicable
Completed
Conditions
Acute Otitis Media
Upper Respiratory Infection
Interventions
Dietary Supplement: Lactobacillus rhamnosus GG
Registration Number
NCT02110732
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

The purpose of this study is to evaluate the effect of oral administration of probiotic Lactobacillus rhamnosus GG in middle ear and adenoid tonsil.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • recurrent otitis media
  • secretory otitis media
  • chronic rhinitis
  • recurrent sinusitis
Exclusion Criteria
  • significant illness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lactobacillus rhamnosus GGLactobacillus rhamnosus GGLactobacillus rhamnosus GG 8-9 x 10 -9 pmy 2x2 for 3 weeks
Crystalline celluloseLactobacillus rhamnosus GGCrystalline cellulose
Primary Outcome Measures
NameTimeMethod
Lactobacillus Rhamnosus GG in Middle Ear Effusion and Adenoid TonsilAfter 3 weeks of oral consumption

Presence of Lactobacillus rhamnosus GG in middle ear effusion of children having tympanostomy after oral administration of L. GG.

Secondary Outcome Measures
NameTimeMethod
Presence of Bacterial Pathogens in Middle Ear Effusion SamplesAfter 3 weeks of oral consumption

Association of Lactobacillus rhamnosus GG with occurrence of bacterial pathogens in the middle ear.

Presence of Rhinovirus and Enterovirus in Middle Ear Effusion SamplesAfter 3 weeks of oral consumption

Association of Lactobacillus rhamnosus GG with occurrence of viral pathogens in the middle ear.

© Copyright 2025. All Rights Reserved by MedPath